ABL, Inc.

ABL, Inc. is a pure contract development and manufacturing organization (CDMO), specializing in the development and manufacturing of viruses for candidate vaccines, gene therapy, and cancer treatment. ABL's mission is to provide GMP viral vectors from the early stages to market, contributing to the success of clients' immunotherapy innovations. ABL's CDMO services include active pharmaceutical ingredients, drug filling/finished products, process and assay development, as well as bioanalytical testing.